6 de marzo de 2026 (12:00)
"Potential for therapeutic targeting of stem cells and their niches in myeloid malignancies"
IJC Auditorium + Online
Inscripción
9 de marzo de 2026 (12:00)
"Defining the genetic and developmental basis of human lymphatic vascular disorders"
IJC Auditorium + Online
Inscripción
12 de marzo de 2026 (12:00)
“New Insights into Risk Stratification for T-cell acute lymphoblastic leukemia”
IJC Auditorium + Online
Inscripción
18 de marzo de 2026 (12:00)
“Stem Cells in Human AML”
IJC Auditorium + Online
Inscripción
20 de marzo de 2026 (12:00)
“Dissecting dynamics of chromatin organization in cell differentiation and cancer"
IJC Auditorium + Online
Inscripción
27 de marzo de 2026 (12:00)
“Microbial viability drives immunometabolic responses in macrophages"
IJC Auditorium + Online
Inscripción
8 de mayo de 2026 (12:00)
“Protein ADP-Ribosylation Controls Innate Immune Responses in Cancer"
IJC Auditorium + Online
Inscripción
15 de mayo de 2026 (12:00)
"Clonal hematopoiesis: disease, risk factor, or evolutionary adaptation?"
IJC Auditorium + Online
Inscripción
3 de julio de 2026 (12:00)
"50 years of measurable residual disease in malignant hemopathies: from submicroscopic detection of resistance to integral monitoring of therapy"
IJC Auditorium + Online
Inscripción
18 de septiembre de 2026 (12:00)
"EPIC-SCENITH and the glycolytic stress response: linking metabolic stress to epigenomic reprogramming in acute myeloid leukemia"
IJC Auditorium + Online
Inscripción